BM-500

N/A

Report date: 2023/12/15 08:45:56
NME

Base Information

Drug NameBM-500
Drug Alias NameBM-500
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet aggregation inhibitorsThromboxane A2 receptor antagonists
TargetsThromboxane A2 synthaseThromboxane A2 receptor
Therapy Area/IndicationsMyocardial InfarctionAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Namur Rucb
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Namur Rucb
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A